By Manufacturing Process

Other Processes (Solid-Phase, Solution-Phase Peptide Synthesis) Market Analysis

Cross-industry research covering Other Processes (Solid-Phase, Solution-Phase Peptide Synthesis) across 1 market reportspanning Pharmaceuticals.

1 Reports
1 Industries

Reports Covering Other Processes (Solid-Phase, Solution-Phase Peptide Synthesis)

Hospital Acquired Infection Control Market to Reach USD 41.6B by 2033 at 6.4% CAGR

Pharmaceuticals·Market: USD 25.3 Billion (2025)·CAGR: 6.4%

Peptide-based antimicrobials and defensin-class compounds use SPPS or solution-phase synthesis with convergent coupling. Though a nascent segment in HAI control, generative chemistry tools are optimizing peptide analog stability and reducing off-target binding, which could accelerate IND submissions for this class within the 2026–2028 window (Claritas model).

12%

Market Share

7.8%

Segment CAGR

Explore More Segments

Browse all market segments across our research coverage.

View all segments